Somerville Kurt F Bristol Myers Squibb CO Transaction History

Somerville Kurt F

$606 Million
Q3 2024

A detailed history of Somerville Kurt F transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Somerville Kurt F holds 6,037 shares of BMY stock, worth $350,146. This represents 0.05% of its overall portfolio holdings.

Number of Shares

6,037

Previous 6,007 0.5%

Holding current value

$350,146

Previous $249,000 25.3%

% of portfolio

0.05%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$39.66 - $51.75 $1,189 - $1,552	30 Added 0.5%	6,037 $312,000
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $61,174 - $69,360	-1,275 Reduced 17.51%	6,007 $325,000
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $58,175 - $69,420	-1,200 Reduced 14.15%	7,282 $373,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $52,101 - $58,257	-900 Reduced 9.59%	8,482 $492,000
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $31,855 - $35,370	-500 Reduced 5.06%	9,382 $599,000
Q1 2023 May 10, 2023	SELL	$65.71 - $74.53 $16,427 - $18,632	-250 Reduced 2.47%	9,882 $684,000
Q2 2022 Jul 19, 2022	SELL	$72.62 - $79.98 $18,155 - $19,995	-250 Reduced 2.41%	10,132 $780,000
Q1 2022 May 17, 2022	SELL	$61.48 - $73.72 $13,833 - $16,587	-225 Reduced 2.12%	10,382 $759,000
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $26,815 - $31,260	-500 Reduced 4.5%	10,607 $661,000
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $51,773 - $60,646	-875 Reduced 7.3%	11,107 $657,000
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $62,359 - $70,664	-1,080 Reduced 8.27%	11,982 $743,000
Q3 2020 Oct 28, 2020	SELL	$57.43 - $63.64 $49,964 - $55,366	-870 Reduced 6.24%	13,062 $787,000
Q2 2020 Jul 28, 2020	SELL	$54.82 - $64.09 $61,398 - $71,780	-1,120 Reduced 7.44%	13,932 $820,000
Q1 2020 May 07, 2020	BUY	$46.4 - $67.43 $213,764 - $310,650	4,607 Added 44.11%	15,052 $839,000
Q4 2019 Jan 15, 2020	BUY	$49.21 - $64.19 $98,173 - $128,059	1,995 Added 23.61%	10,445 $670,000
Q2 2019 Jul 24, 2019	SELL	$44.62 - $49.34 $32,349 - $35,771	-725 Reduced 7.9%	8,450 $384,000
Q1 2019 May 01, 2019	SELL	$45.12 - $53.8 $25,944 - $30,935	-575 Reduced 5.9%	9,175 $438,000
Q4 2018 Jan 24, 2019	SELL	$48.76 - $63.23 $21,942 - $28,453	-450 Reduced 4.41%	9,750 $507,000
Q3 2018 Oct 15, 2018	SELL	$55.19 - $62.25 $30,354 - $34,237	-550 Reduced 5.12%	10,200 $633,000
Q2 2018 Jul 30, 2018	SELL	$50.53 - $62.98 $61,899 - $77,150	-1,225 Reduced 10.23%	10,750 $595,000
Q1 2018 Apr 24, 2018	SELL	$59.92 - $68.98 $19,474 - $22,418	-325 Reduced 2.64%	11,975 $757,000
Q4 2017 Feb 02, 2018	SELL	$59.94 - $65.35 $512,487 - $558,742	-8,550 Reduced 41.01%	12,300 $754,000
Q3 2017 Oct 26, 2017	BUY	$55.23 - $63.74 $1.15 Million - $1.33 Million	20,850	20,850 $1.33 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Somerville Kurt F, based on Form 13F filings with the SEC.

News

Stay updated on Somerville Kurt F with notifications on news.

Account

Somerville Kurt F Bristol Myers Squibb CO Transaction History